TMS to Treat Core Social Deficits in Autism Spectrum Disorder
- Study HIC#:2000030576
- Last Updated:02/22/2024
This study will evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS), a type of noninvasive brain stimulation, on the social brain. TMS is a therapy that has been approved for depression and obsessive-compulsive disorder and we are looking to see if it can also help those with ASD. This method uses magnetic waves administered in a train of pulses to influence brain activity. A participant visit includes a baseline assessment of neuropsychological, cognitive and behavioral function and an EEG and eye-tracking session to measure visual and social responses before and after TMS.
Participation consists of 2 visits and compensation is $100 per visit.
We are seeking participants diagnosed with autism or typical development between the ages of 18 to 30 years old.
- Age18 years - 30 years
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Our Team
- Phone Number: 1-203-737-3439
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
This study will evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS), a type of noninvasive brain stimulation, on the social brain. TMS is a therapy that has been approved for depression and obsessive-compulsive disorder and we are looking to see if it can also help those with ASD. This method uses magnetic waves administered in a train of pulses to influence brain activity. A participant visit includes a baseline assessment of neuropsychological, cognitive and behavioral function and an EEG and eye-tracking session to measure visual and social responses before and after TMS.
Participation consists of 2 visits and compensation is $100 per visit.
We are seeking participants diagnosed with autism or typical development between the ages of 18 to 30 years old.
Eligibility Criteria
Inclusion Criteria:
- Age: 18-30
- Gender: Both
- Adults with diagnosis of ASD or typical development